Wes Metheny

Wes Metheny designs and leads major public affairs campaigns and provides strategic business insights for innovators in health care, including biopharmaceutical companies, medical device manufacturers, and consumer health companies. Prior to starting PQP, Wes led the transformation of the Pharmaceutical Research and Manufacturers of America into one of the nation's most effective advocacy organizations and recognized force for public policies that support access to medicines and future medical advancements. As PhRMA's Senior Vice President of Advocacy, Wes developed a network of alliances and strategies to impact public policies with organizations representing patients, healthcare providers, business leaders, organized labor, minorities and the disabled, and formulated campaign strategies to shape public opinion.


During the national debate on health care reform, Wes led PhRMA's national advocacy campaign to help shape and pass the Affordable Care Act. Under his leadership, PhRMA also created many successful initiatives to support the lives of patients, including the Partnership to Fight Chronic Disease, the Medicare Rx Education Network and the Partnership for Prescription Assistance, the world's largest private sector assistance program for uninsured and underinsured patients.

Prior to joining PhRMA, Wes served as Director of Government Affairs and Grassroots for the Healthcare Leadership Council, a coalition of chief executives of the nation's leading healthcare companies, and worked for the U.S. Senate Sergeant-at-Arms.

Wes graduated from the University of Maryland and lives in Annapolis, Maryland with his wife and three children.

ADVERTISEMENT

Suffering From Chronic Pain as a Black Woman

Bias can lead to disparities in diagnosis and treatment of Black women with chronic pain

Chronic Care Issues

Your Child’s Vaccines: What You Need to Know About Catching Up During the COVID-19 Pandemic

Vaccination rates dropped by as much as 60% in some parts of the country due to COVID-19. It's time to get back on track

Prevention & Screenings

Corralling the Facts on Herd Immunity

The effectiveness of herd immunity is a hotly debated topic. Time to separate fact from fiction

Prevention & Screenings